Evidence map›Paper›PMID 26125563›Full record

ArticlePLoS genetics2015

Independent Neuronal Origin of Seizures and Behavioral Comorbidities in an Animal Model of a Severe Childhood Genetic Epileptic Encephalopathy.

Samuel K Asinof, Stacey J Sukoff Rizzo, Alexandra R Buckley, Barbara J Beyer, Verity A Letts, Wayne N Frankel, Rebecca M Boumil

Open access · goldAbstract read
In one paragraph

Article in PLoS genetics, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
2.0field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 38 citations in OpenAlex.

  1. Review
  2. Effective knockdown-replace gene therapy in a novel mouse model of DNM1 developmental and epileptic encephalopathy.Molecular therapy : the journal of the American Society of Gene Therapy · 2024
    Article
  3. GABAergic/Glycinergic and Glutamatergic Neurons Mediate Distinct Neurodevelopmental Phenotypes ofThe Journal of neuroscience : the official journal of the Society for Neuroscience · 2024
    Article
  4. Article
  5. Article
  6. Review
  7. RNAi-Based Gene Therapy Rescues Developmental and Epileptic Encephalopathy in a Genetic Mouse Model.Molecular therapy : the journal of the American Society of Gene Therapy · 2020
    Article
  8. Article
  9. GABABrain communications · 2020
    Article
  10. Article
  11. Article
  12. Confirming the pathogenicity ofEpilepsia open · 2018
    Article
  13. Review
  14. Article
  15. Article
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Samuel K AsinofThe Jackson Laboratory, Bar Harbor, Maine, United States of America.
Stacey J Sukoff RizzoThe Jackson Laboratory, Bar Harbor, Maine, United States of America.
Alexandra R BuckleyBiomedical Sciences Graduate Program, University of California, San Diego, San Diego, California, United States of America.
Barbara J BeyerThe Jackson Laboratory, Bar Harbor, Maine, United States of America.
Verity A LettsThe Jackson Laboratory, Bar Harbor, Maine, United States of America.
Wayne N FrankelThe Jackson Laboratory, Bar Harbor, Maine, United States of America.
Rebecca M BoumilThe Jackson Laboratory, Bar Harbor, Maine, United States of America.
Jackson Laboratory · USUniversity of California, San Diego · US

Funding

Genetic Determinants of Epilepsy in Murine SystemsR37NS031348 · NINDS · JACKSON LABORATORY · PI FRANKEL, WAYNE N. · 2014 to 2020
$5.8M
The Genetics and Cell Biology of the Epileptic Mouse Mutant FitfulR01NS073576 · NINDS · JACKSON LABORATORY · PI BOUMIL, REBECCA M · 2011 to 2014
$1.2M
NINDS NIH HHS R01 NS073576NINDS NIH HHS R37 NS031348
6 · The paper itself

Abstract

The childhood epileptic encephalopathies (EE's) are seizure disorders that broadly impact development including cognitive, sensory and motor progress with severe consequences and comorbidities. Recently, mutations in DNM1 (dynamin 1) have been implicated in two EE syndromes, Lennox-Gastaut Syndrome and Infantile Spasms. Dnm1 encodes dynamin 1, a large multimeric GTPase necessary for activity-dependent membrane recycling in neurons, including synaptic vesicle endocytosis. Dnm1Ftfl or "fitful" mice carry a spontaneous mutation in the mouse ortholog of DNM1 and recapitulate many of the disease features associated with human DNM1 patients, providing a relevant disease model of human EE's. In order to examine the cellular etiology of seizures and behavioral and neurological comorbidities, we engineered a conditional Dnm1Ftfl mouse model of DNM1 EE. Observations of Dnm1Ftfl/flox mice in combination with various neuronal subpopulation specific cre strains demonstrate unique seizure phenotypes and clear separation of major neurobehavioral comorbidities from severe seizures associated with the germline model. This demonstration of pleiotropy suggests that treating seizures per se may not prevent severe comorbidity observed in EE associated with dynamin-1 mutations, and is likely to have implications for other genetic forms of EE.

Indexed as

AnimalsBehavior, AnimalDisease Models, AnimalDynamin IElectroencephalographyEpilepsyFemaleGene DeletionHumansInfantLennox Gastaut SyndromeMaleMice, Mutant StrainsNeuronsPhenotypeProsencephalonDynamin I

Identifiers

PMID26125563
PMCPMC4488318
OpenAlexW828310207

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.